AzTrials
AzTrials

Muscle DiastasisMIRRADRCTNCT05759663

MIRRAD Versus Plication of Entire Diastasis Trial

A study testing MIRRAD and Plication of the entire diastasis arm in people with Muscle Diastasis, run by Karolinska Institutet at 2 sites in Sweden.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Background Postpartum diastasis of the rectus abdominis muscles (DRAM) has gained increasing attention as a condition that may affect abdominal trunk function but that may be alleviated by surgery. Read more about this study

Who is it for?
Ages 20 to 50 years, women only
Conditions the study is for
Muscle Diastasis
What is being tested?
MIRRAD and Plication of the entire diastasis arm
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
2 sitesSweden
Study dates
1 Aug 2025to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Women having undergone at least one pregnancy
  • Age 20 - 50 years
  • Minimum 2 cm diastasis of rectus abdominis muscle at the level of the umbilicus
  • BMI < 30
  • Treatment failure after six months of structured training

Who cannot join

  • Nulliparous women
  • Less than one year since last pregnancy
  • Women who have not undergone structured training for at least six months
  • Previous abdominal surgery through open midline incision
  • Presence of excessive skin folds
  • Future planned pregnancies

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Gabriel Sandblom, Ass Prof contact

+46704158218

gabriel.sandblom@ki.se

Sweden2 sites
  • Department of Surgery, Karloskoga Hospital

    Karlskoga, 69144

  • Stockholm South General Hospital

    Stockholm, 11883

Other trials in Sweden

About this study

Official title: Randomized Controlled Trial of Minimal Incision Repair of Rectus Abdominis Diastasis Versus Repair of the Entire Diastasis

Background Postpartum diastasis of the rectus abdominis muscles (DRAM) has gained increasing attention as a condition that may affect abdominal trunk function but that may be alleviated by surgery. Most techniques for surgical reconstruction of DRAM are, however, associated with high costs, postoperative pain and risk of surgical complications. The aim of the present study is to evaluate a Minimal Incision Repair of Rectus Abdominis Diastasis (MIRRAD) in a randomized controlled open label trial. Altogether 120 women will be included.

Population Postpartum women with DRAM of at least 2 cm.

Read more

Intervention Plication of Linea alba through a 3-5 centimeter long incision at the level of the umbilicus

Control Plication of the entire Linea alba through a low transverse incision.

Outcome Primary outcome: Abdominal function rated with the Disability Rating Index Secondary outcomes: Operative time, postoperative stay, surgical complications, sick leave, persisting pain orated with the Ventral Pain Hernia Questionnaire, cosmetic outcome rated with BODY-Q

Follow-up Follow-up one month and one year after surgery

Significance If the study shows that MIRRAD is equally effective as plication of the entire Linea alba one year after surgery, it may be introduced as a standard technique for DRAM. If it is not as effective, it may still be an alternative with advantages in terms of cost benefit and the possibility to perform it as a daycare procedure.

Read the detailed description

Background

Diastasis of the rectus abdominis muscles (DRAM) is a well-known phenomenon that until recently has not attracted much attention. It may either develop in high age, often in combination with truncal obesity, or as the result of one or more pregnancies. Several studies, have, however, shown that post-partum DRAM may cause impaired abdominal trunk function, often combined with pelvic floor dysfunction and back pain. Studies have also shown that these problems can be reduced with surgery aimed at restoring the integrity of the Linea alba [1-3] The favorable outcomes in well-selected samples of post-partum women [4] have resulted in a widespread demand for broadened indications and that such surgery should be offered routinely to all post-partum women with abdominal trunk dysfunction. However, concerns have been raised regarding the costs and potential hazards from such a procedure for a condition that is associated with abdominal function impairment but no potential serious morbidity.

The surgical techniques for restoring abdominal wall function in women with postpartum DRAM are mainly based on experience from ventral hernia surgery. The aim of ventral hernia surgery is ultimately to reduce the hernia sac to the abdominal cavity and closing the hernia defect in a way that the risk of recurrences is minimized. This may either be carried with an open or endoscopic technique, and with or without mesh reinforcement. Most studies on DRAM surgery are thus focused on strengthening the entire Linea alba and minimizing the risk for recurrence. In case of restoring the abdominal trunk function in DRAM, however, the aim should rather be to prevent the rectus muscles from separating during tension and thereby leaving room for the midline bulge of the abdominal trunk and loss of tonus in the abdominal wall.

Surgery for DRAM should thus aimed at being cost-effective and atraumatic enough to be offered for a very large number of women in need of treatment for DRAM as well as to be safe enough to ensure that postoperative complications and early recurrences are not seen. For that purpose, we intend to evaluate a surgical technique that limits the surgical trauma and could be carried out in a large scale without need of great resources.

Study design

The study will be conducted as an open label randomized controlled trial where an established and evaluated technique, i.e., plication of the dilated part of Linea alba with open technique through a low transverse skin incision will be compared with MIRRAD. Before inclusion the woman should have undergone an organized training program without satisfying result. After consent has been given, the patient is randomized between MIRRAD or plication of the entire DRAM. Prior to surgery the patient undergoes examination by a physiotherapist and the Abdominal Trunk Function Protocol is completed. Regardless of allocation, the procedure is carried out under general anesthesia.

MIRRAD arm A 3 cm vertical incision is made above the umbilicus. The umbilicus is de-attached from the Linea alba so that Linea alba 5-7 cm above and 3-5cm below the umbilicus is exposed. The abdominal rectus muscle diastasis is then plicated with double layer barbed suture. The first suture line is over and over continuous suture and the second suture line continuous suture line. The umbilicus is then re-attached with a single stich . The skin is closed with continuous intradermal sutures.

Plication of the entire diastasis arm A low transverse incision is made and the subcutaneous tissue along the Linea alba dissected. If there is any hernia present in the Linea alba, it is invaginated in a plicated suture line. The entire DRAM along the Linea alba is plicated with continuous sutures. Excessive skin and subcutaneous tissue along the incision is excised and the wound closed. The subcutaneous tissue is closed with interrupted 4-0 PDS® stitches. The skin is closed with continuous intradermal sutures.

Follow-up Four hours after the procedure is completed the woman is requested to rate pain and nausea on VAS scales. All included women are invited to follow-up one month and one year after surgery. At the follow-up one month after surgery, postoperative complications, day of return to work are registered and the abdominal function is rated according to the Disability Rating Index of the Abdominal Trunk Function Protocol and persisting pain according to the Ventral Hernia Pain Questionnaire. At the one year postoperatively abdominal function is evaluated according to the Abdominal Trunk Function Protocol, persisting pain with Ventral Hernia Pain Questionnaire and cosmetic outcome with the belly contour items of the BODY-Q questionnaire

Being tested
MIRRAD, Plication of the entire diastasis arm
Keywords
Postpartum, Diastasis of the Rectus Abdominis Muscles, Surgery
Medical subject headings
Diastasis, Muscle

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MIRRADProcedure or surgery

    Repair of the diastasis with MIRRAD technique

  • Plication of the entire diastasis armProcedure or surgery

    Plication of the entire diastasis

Study groups in NCT05759663
Study groupRoleWhat they receive
MIRRADExperimentalA 3 cm vertical incision is made above the umbilicus. The umbilicus is de-attached from the Linea alba so that Linea alba 5-7 cm above and 3-5cm below the umbilicus is exposed. The abdominal rectus muscle diastasis is then plicated with double layer barbed suture. The first suture line is over and over continuous suture and the second suture line continuous suture line. The umbilicus is then re-attached with a single stich .
Receives: Procedure: MIRRAD
Plication of the entire diastasis armActive comparatorA low transverse incision is made and the subcutaneous tissue along the Linea alba dissected. If there is any hernia present in the Linea alba, it is invaginated in a plicated suture line. The entire DRAM along the Linea alba is plicated with continuous sutures. Excessive skin and subcutaneous tissue along the incision is excised and the wound closed. The subcutaneous tissue is closed with interrupted 4-0 PDS stitches.
Receives: Procedure: Plication of the entire diastasis arm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Abdominal trunk function

    Abdominal function assessed with Abdominal Trunk Function Protocol one year after surgery

    Measured: One year

Secondary outcomes (10)
  1. Operation time

    Time required to complete the procedure

    Measured: Two hours

  2. Postoperative pain 4 hours after surgery

    Pain rated on a VAS scale

    Measured: Four hours

  3. Postoperative nausea 4 hours after surgery

    Nausea rated on a VAS scale

    Measured: Four hours

  4. Time from surgery to discharge

    Time from surgery to the moment when the patient is discharged

    Measured: Seven days

  5. Surgical complications

    Complications related to the procedure rated according to Clavien-Dindo

    Measured: Thirty days

  6. Postoperative sick leave

    Time from surgery to full return to work

    Measured: Thirty days

  7. Postoperative seroma

    Subcutaneous confirmed at clinical examination 30 days postoperatively

    Measured: Thirty days

  8. Pain from abdominal wall

    Pain from abdominal wall rated with VHPQ one month and one year after surgery

    Measured: One year

  9. Abdominal Trunk function

    Abdominal Trunk function assessed with Abdominal Trunk Function Protocol one month after surgery

    Measured: One month

  10. Cosmetic satisfaction

    Cosmetic outcome rated with BODY-Q one year after surgery

    Measured: One year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Mar 2023
  2. Study start1 Aug 2025 (estimated)
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05759663
Sponsor's protocol ID
MIRRAD RCT
Acronym
MIRRADRCT
Status last verified
Jan 2025
First submitted
26 Feb 2023
Last updated
3 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing MIRRAD and Plication of the entire diastasis arm in people with Muscle Diastasis, run by Karolinska Institutet at 2 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gabriel Sandblom, Ass Prof (+46704158218, gabriel.sandblom@ki.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Abdominal trunk function (time frame: One year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in